drugset / Trial / NCT04672720

L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles

NCT04672720

Completed 110 enrolled Royan Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study was to evaluate the effect of oral L-carnitine supplementation during controlled ovarian stimulation (COS) in patients with polycystic ovary syndrome (PCOS) in a double-blind randomized clinical trial. The eligible patients with PCOS diagnosis (on the basis of Rotterdam criteria) who referred to Royan Research Institute for IVF / ICSI treatment cycles will be evaluated.

Timeline

Start
2020-03-01
Primary completion
2022-12-29
Completion
2023-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified 1000 mg Oral